Duke, I am putting management to the fire and will continue to do so until they come to the realization that they are destroying whatever shareholder equity is left by failing to get recaf approved for "something". Why are they basically holding onto years of research, but willing to throw substantial amounts of money out the window year after year to "advertise" the company which has done more damage and attracted the worst kind of daytraders to the stock.
At this point, I will be the first to congratulate Dr Moro and apologize for my disparaging remarks if he is working behind the scenes getting all of his ducks in a row in anticipation of applying to the FDA. If he isn't, I will be relentless in my pursuit to get the sand out of his eyes, and make him aware that this stock has lost 99% of its value since the high in 2004. It's been painful to watch the equity markets return to normal levels and this stock which has no liquidity, has only further deteriorated.
I guess we'll never know if recaf could have saved human lives or caught cancer early since there seems to be no rush to get recaf approved. Shameful. What a pity.
